119 related articles for article (PubMed ID: 29703639)
1. [Angiosarcoma of the head and neck treated with bevacizumab and paclitaxel].
Becquart O; Girard C; Lesage C; Guillot B
Ann Dermatol Venereol; 2018; 145(6-7):451-453. PubMed ID: 29703639
[No Abstract] [Full Text] [Related]
2. Unresectable angiosarcoma treated with bevacizumab and paclitaxel.
Nespereira-Jato MV; Peña-Panabad C; Quindós-Varela M; García-Silva J
Actas Dermosifiliogr; 2014 Jun; 105(5):520-2. PubMed ID: 24144236
[No Abstract] [Full Text] [Related]
3. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial.
Lebellec L; Bertucci F; Tresch-Bruneel E; Ray-Coquard I; Le Cesne A; Bompas E; Blay JY; Italiano A; Mir O; Ryckewaert T; Toiron Y; Camoin L; Goncalves A; Penel N; Le Deley MC
BMC Cancer; 2018 Oct; 18(1):963. PubMed ID: 30305054
[TBL] [Abstract][Full Text] [Related]
5. Complete remission in a patient with multifocal metastatic cutaneous angiosarcoma with a combination of paclitaxel and sorafenib.
Donghi D; Dummer R; Cozzio A
Br J Dermatol; 2010 Mar; 162(3):697-9. PubMed ID: 20030640
[No Abstract] [Full Text] [Related]
6. Congenital angiosarcoma with transient response to paclitaxel.
Good AB; Nascimento A; Welker KM; Arndt CA
J Pediatr Hematol Oncol; 2008 Jun; 30(6):451-3. PubMed ID: 18525462
[TBL] [Abstract][Full Text] [Related]
7. First sonographic description of idiopathic Cutaneous Angiosarcoma of the Head and Neck.
Vilas Boas P; Ruedas Martínez A; Baniandrés Rodriguez O; Ciudad Blanco C
Actas Dermosifiliogr; 2017 Dec; 108(10):960-962. PubMed ID: 28803613
[No Abstract] [Full Text] [Related]
8. Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel.
Pestoni C; Paredes-Suarez C; Peteiro C; Toribio J
J Eur Acad Dermatol Venereol; 2005 May; 19(3):357-9. PubMed ID: 15857466
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial.
Ray-Coquard IL; Domont J; Tresch-Bruneel E; Bompas E; Cassier PA; Mir O; Piperno-Neumann S; Italiano A; Chevreau C; Cupissol D; Bertucci F; Bay JO; Collard O; Saada-Bouzid E; Isambert N; Delcambre C; Clisant S; Le Cesne A; Blay JY; Penel N
J Clin Oncol; 2015 Sep; 33(25):2797-802. PubMed ID: 26215950
[TBL] [Abstract][Full Text] [Related]
10. Combined nab-paclitaxel and irradiation for large cutaneous angiosarcoma of the face and scalp with pulmonary metastases.
André F; Frischhut N; Walder A; Skvortsov S; Schmuth M; Nguyen VA
J Dtsch Dermatol Ges; 2020 Jul; 18(7):754-757. PubMed ID: 32469459
[No Abstract] [Full Text] [Related]
11. Weekly low-dose docetaxel in the treatment of lung metastases from angiosarcoma of the head.
Yamada M; Hatta N; Mizuno M; Oishi N; Takehara K
Br J Dermatol; 2005 Apr; 152(4):811-2. PubMed ID: 15840125
[No Abstract] [Full Text] [Related]
12. Angiosarcoma of the scalp successfully treated with a single therapy of sorafenib.
Ono S; Tanioka M; Fujisawa A; Tanizaki H; Miyachi Y; Matsumura Y
Arch Dermatol; 2012 Jun; 148(6):683-5. PubMed ID: 22710450
[No Abstract] [Full Text] [Related]
13. Angiosarcoma of the scalp treated with OK-432 and rIL-2.
Miura H; Inui S; Sakai H; Hasebe N; Itami S; Yoshikawa K
Int J Dermatol; 2002 May; 41(5):286-8. PubMed ID: 12100706
[No Abstract] [Full Text] [Related]
14. Complete remission of treatment-refractory advanced angiosarcoma of the scalp by protracted intralesional interleukin-2 therapy.
Gebhardt C; Ziegler B; Stadler S; Goerdt S; Utikal J
Br J Dermatol; 2015 Apr; 172(4):1156-8. PubMed ID: 25204400
[No Abstract] [Full Text] [Related]
15. [Angiosarcoma in primary lymphoedema: A rare complication].
Farhat MM; Le Guern A; Peugniez C; Dabouz F; Quinchon JF; Modiano P
Ann Dermatol Venereol; 2018 Apr; 145(4):266-269. PubMed ID: 29530502
[TBL] [Abstract][Full Text] [Related]
16. A case of cutaneous angiosarcoma successfully treated with eribulin.
Iwamoto K; Fujisawa Y; Ishitsuka Y; Maruyama H; Nakamura Y; Okiyama N; Watanabe R; Fujimoto M
Eur J Dermatol; 2018 Jun; 28(3):410-412. PubMed ID: 29619993
[No Abstract] [Full Text] [Related]
17. Complete long-term response of angiosarcoma of the scalp with cervical lymph node metastases treated with a combination of weekly and monthly docetaxel.
Nakamura Y; Nakamura Y; Hori E; Furuta J; Kawachi Y; Otsuka F
Br J Dermatol; 2010 Dec; 163(6):1357-8. PubMed ID: 20731655
[No Abstract] [Full Text] [Related]
18. Angiosarcoma of the scalp responding to nivolumab: a case report.
Hofer S; Zeidler K; Schipf A; Kempf W; Zimmermann D; Aebi S
Br J Dermatol; 2018 Aug; 179(2):530-531. PubMed ID: 29700818
[No Abstract] [Full Text] [Related]
19. Pazopanib can preserve cosmetic quality of life even in end-stage angiosarcoma.
Kitamura S; Hata H; Imafuku K; Haga N; Homma E; Shimizu H
Clin Exp Dermatol; 2015 Dec; 40(8):931-3. PubMed ID: 25817046
[No Abstract] [Full Text] [Related]
20. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
Fata F; O'Reilly E; Ilson D; Pfister D; Leffel D; Kelsen DP; Schwartz GK; Casper ES
Cancer; 1999 Nov; 86(10):2034-7. PubMed ID: 10570428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
